Search

everythinglearnresearchcommunity

for

Search:↓

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

New therapies are being developed that target integrin pathways to treat various diseases.

ADCs can effectively treat breast cancer but may cause side effects like nausea and hair loss.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Oral minoxidil can help regrow hair lost from antibody-drug conjugate treatment.

Extracellular vesicles show promise for treating diseases but face challenges in development and regulation.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Engineered exosomes show promise for improving wound healing but face challenges in clinical use.

Distinct β-catenin patterns are linked to cell growth, not cell death, in lung cancer.

Collagen XVII is important for skin aging and wound healing.

Researchers developed a sensitive method to measure minoxidil in various products with high accuracy.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Printing human stem cells and a special matrix during surgery can help grow new skin and hair-like structures in rats.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

In 2024, the FDA approved 50 new drugs, including treatments for hair loss, anemia, high blood pressure, and Alzheimer's.

Scalp cooling helps prevent hair loss during chemotherapy, and minoxidil aids regrowth.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Exosomes may help treat skin diseases and improve skin rejuvenation.

AcD scaffolds improve tissue repair and regeneration by combining stem cells with a supportive matrix.

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.

AGD1 is important for root hair development in Arabidopsis, working with phosphoinositide signaling and the actin cytoskeleton.

ADSCs help protect skin from UV damage and aging.

ADM scaffolds help skin heal by promoting a healing-type immune response.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

CCDC22 and CCDC93 are essential for root and root hair growth in Arabidopsis.

ODC1 gene mutations cause a neurodevelopmental disorder with large head size, hair loss, and facial abnormalities.

AGD1's PH domain is essential for its role in root hair growth and polarity.

Combining DHT and EDC improves the strength and stability of PADM scaffolds for tissue engineering.

Patients with central centrifugal cicatricial alopecia benefit from shared decision-making with their doctors.

A gene called APCDD1, which controls hair growth, is found to be faulty in a type of hair loss called hereditary hypotrichosis simplex.